Glucans as New Anticancer Agents.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F19%3A00520914" target="_blank" >RIV/61388971:_____/19:00520914 - isvavai.cz</a>

Result on the web

<a href="https://www.ingentaconnect.com/content/nhn/pimj/2019/00000043/00000001/art00007" target="_blank" >https://www.ingentaconnect.com/content/nhn/pimj/2019/00000043/00000001/art00007</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.21873/anticanres.13480" target="_blank" >10.21873/anticanres.13480</a>

Result language

angličtina

Original language name

Glucans as New Anticancer Agents.

Original language description

For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.

Czech name

—

Czech description

—

Type

J_ost - Miscellaneous article in a specialist periodical

CEP classification

—

OECD FORD branch

10606 - Microbiology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Anticancer Research

ISSN

0250-7005

e-ISSN

—

Volume of the periodical

39

Issue of the periodical within the volume

7

Country of publishing house

GR - GREECE

Number of pages

6

Pages from-to

3373-3378

UT code for WoS article

000482700300010

EID of the result in the Scopus database

2-s2.0-85068262023